A 68-year-old man with prostate cancer developed penile metastasis, a rare but serious complication, reinforcing the need for thorough examination and early detection.

For patients with prostate cancer, genetic testing can be crucial, as one expert recently noted. “We know that prostate cancer has a strong genetic association, and for patients with prostate cancer, ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S ...

The first patient has been dosed in a phase 1/2 trial evaluating a novel treatment combination of gotistobart (BNT316/ONC-392) and Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in certain patients ...

For patients facing advanced prostate cancer, the idea of surgery is not a one-size-fits-all solution. It’s a highly nuanced decision that requires thoughtful discussion, personalized counseling ...

The study of prostate cancer patients in the VA system found some with limited life expectancy were being treated with procedures that did not add more years to their lives.

Prostate Cancer Awareness: Inspiring Stories from Patients and Those Who Care for Them PEOPLE and Verywell Health joined forces to share the facts about prostate cancer, plus unique perspectives ...

Prostate cancer remains the only common cancer without a screening programme. The National Screening Committee will reach a decision this year, following evidence submitted by Prostate Cancer UK.

In this moment, patients like Mr. Biden and others who develop metastatic prostate cancer diagnoses are more fortunate than patients in the past. There are about 10 new treatments for the disease ...